Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D2-Based Pharmacological Class Effect Query Defined by FAERS

Citation:

Hopkins, S.C., Ogirala, A., Zeni, C. et al. Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D2-Based Pharmacological Class Effect Query Defined by FAERS. Clin Drug Investig 42, 1113–1121 (2022). https://doi.org/10.1007/s40261-022-01218-7